NYMC Faculty Publications

Human Mesenchymal Stem Cells Modulate Inflammatory Cytokines After Spinal Cord Injury in Rat

Lucia Machová Urdzíková, Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Vídeňská 1083, Prague 14220, Czech Republic. urdzikl@saske.sk.
Jiří Růžička, Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Vídeňská 1083, Prague 14220, Czech Republic. j.ruzicka@biomed.cas.cz.
Michael LaBagnara, Department of Neurosurgery, New York Medical College, Valhalla, NY 10595, USA. m.labagnara@gmail.com.
Kristýna Kárová, Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Vídeňská 1083, Prague 14220, Czech Republic. karova@biomed.cas.cz.
Šárka Kubinová, Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Vídeňská 1083, Prague 14220, Czech Republic. sarka.k@biomed.cas.cz.
Klára Jiráková, Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Vídeňská 1083, Prague 14220, Czech Republic. jirakova@biomed.cas.cz.
Raj Murali, Department of Neurosurgery, New York Medical College, Valhalla, NY 10595, USA. Raj_Murali@NYMC.edu.
Eva Syková, Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Vídeňská 1083, Prague 14220, Czech Republic. sykova@biomed.cas.cz.
Meena Jhanwar-Uniyal, Department of Neurosurgery, New York Medical College, Valhalla, NY 10595, USA. meena_jhanwar@NYMC.edu.
Pavla Jendelová, Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Vídeňská 1083, Prague 14220, Czech Republic. jendel@biomed.cas.cz.

Author Type(s)

Faculty

DOI

10.3390/ijms150711275

Journal Title

International Journal of Molecular Sciences

First Page

11275

Last Page

93

Document Type

Article

Publication Date

6-25-2014

Abstract

Transplantation of mesenchymal stem cells (MSC) improves functional recovery in experimental models of spinal cord injury (SCI); however, the mechanisms underlying this effect are not completely understood. We investigated the effect of intrathecal implantation of human MSC on functional recovery, astrogliosis and levels of inflammatory cytokines in rats using balloon-induced spinal cord compression lesions. Transplanted cells did not survive at the lesion site of the spinal cord; however, functional recovery was enhanced in the MSC-treated group as was confirmed by the Basso, Beattie, and Bresnahan (BBB) and the flat beam test. Morphometric analysis showed a significantly higher amount of remaining white matter in the cranial part of the lesioned spinal cords. Immunohistochemical analysis of the lesions indicated the rearrangement of the glial scar in MSC-treated animals. Real-time PCR analysis revealed an increased expression of Irf5, Mrc1, Fgf2, Gap43 and Gfap. Transplantation of MSCs into a lesioned spinal cord reduced TNFα, IL-4, IL-1β, IL-2, IL-6 and IL-12 and increased the levels of MIP-1α and RANTES when compared to saline-treated controls. Intrathecal implantation of MSCs reduces the inflammatory reaction and apoptosis, improves functional recovery and modulates glial scar formation after SCI, regardless of cell survival. Therefore, repeated applications may prolong the beneficial effects induced by MSC application.

This document is currently not available here.

Share

COinS